129 related articles for article (PubMed ID: 15022387)
1. [Technetium-99m-tetrofosmin radionuclide mammography in the diagnosis of malignant breast tumors].
Jauković L
Vojnosanit Pregl; 2004; 61(1):35-40. PubMed ID: 15022387
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
4. Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses.
Kim IJ; Kim SJ; Kim YK
Neoplasma; 2008; 55(6):526-31. PubMed ID: 18999882
[TBL] [Abstract][Full Text] [Related]
5. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases.
Mansi L; Rambaldi PF; Procaccini E; Gregorio FD; Laprovitera A; Pecori B; Vecchio WD
Eur J Nucl Med; 1996 Aug; 23(8):932-9. PubMed ID: 8753682
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
8. Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses.
Lee JS; Kim SJ; Kim IJ; Bae YT; Kim YK; Kang YS; Kim DS
Eur J Radiol; 2006 Jan; 57(1):76-80. PubMed ID: 16125892
[TBL] [Abstract][Full Text] [Related]
9. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
10. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
[TBL] [Abstract][Full Text] [Related]
11. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions.
Liu L; Song Y; Gao S; Ji T; Zhang H; Ji B; Chen B; Jia B; Wang F; Xu Z; Ma Q
Mol Imaging; 2014; 13(5):. PubMed ID: 24825112
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography.
Habib S; Maseeh-uz-Zaman ; Hameed A; Niaz K; Hashmi H; Kamal S
J Coll Physicians Surg Pak; 2009 Oct; 19(10):622-6. PubMed ID: 19811712
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.
Buscombe JR; Cwikla JB; Holloway B; Hilson AJ
J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976
[TBL] [Abstract][Full Text] [Related]
14. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
[TBL] [Abstract][Full Text] [Related]
17. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
18. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.
Obwegeser R; Berghammer P; Rodrigues M; Granegger S; Hohlagschwandtner M; Kucera H; Singer C; Berger A; Kubista E; Sinzinger H
Eur J Nucl Med; 1999 Dec; 26(12):1553-9. PubMed ID: 10638406
[TBL] [Abstract][Full Text] [Related]
19. Detection of malignant breast tumours in dense breast tissue: results of 99mTc-tetrofosmin scintimammography related to surgery.
Bongers V; Borel Rinkes IH; Sie-Go DM; Pijnappel R; de Hooge P; van Rijk PP
Eur J Surg Oncol; 1999 Apr; 25(2):152-6. PubMed ID: 10218457
[TBL] [Abstract][Full Text] [Related]
20. Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer.
Melloul M; Paz A; Ohana G; Laver O; Michalevich D; Koren R; Wolloch Y; Gal R
J Nucl Med; 1999 Mar; 40(3):376-80. PubMed ID: 10086698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
